TABLE 1. GLOBAL EARLY TOXICITY TESTING MARKET, BY TECHNIQUE 2014-2022 ($MILLION)
TABLE 2. GLOBAL IN VIVO EARLY TOXICITY TESTING MARKET, BY GEOGRAPHY 2014-2022 ($MILLION)
TABLE 3. GLOBAL IN VITRO EARLY TOXICITY TESTING MARKET, BY GEOGRAPHY 2014-2022 ($MILLION)
TABLE 4. GLOBAL IN VITRO EARLY TOXICITY TESTING MARKET, BY ASSAY 2014-2022 ($MILLION)
TABLE 5. GLOBAL IN VITRO EARLY TOXICITY TESTING MARKET, BY TOXICITY END-POINTS 2014-2022 ($MILLION)
TABLE 6. GLOBAL IN SILICO EARLY TOXICITY TESTING MARKET, BY GEOGRAPHY 2014-2022 ($MILLION)
TABLE 7. GLOBAL EARLY TOXICITY TESTING MARKET, BY END USERS 2014-2022 ($MILLION)
TABLE 8. GLOBAL EARLY TOXICITY TESTING PHARMACEUTICAL INDUSTRY MARKET, BY GEOGRAPHY 2014-2022 ($MILLION)
TABLE 9. GLOBAL EARLY TOXICITY TESTING DIAGNOSTICS INDUSTRY MARKET, BY GEOGRAPHY 2014-2022 ($MILLION)
TABLE 10. GLOBAL EARLY TOXICITY TESTING FOOD INDUSTRY MARKET, BY GEOGRAPHY 2014-2022 ($MILLION)
TABLE 11. GLOBAL EARLY TOXICITY TESTING CHEMICAL INDUSTRY MARKET, BY GEOGRAPHY 2014-2022 ($MILLION)
TABLE 12. GLOBAL EARLY TOXICITY TESTING COSMETICS INDUSTRY MARKET, BY GEOGRAPHY 2014-2022 ($MILLION)
TABLE 13. GLOBAL EARLY TOXICITY TESTING PHARMACEUTICAL INDUSTRY MARKET, BY GEOGRAPHY 2014-2022 ($MILLION)
TABLE 14. GLOBAL EARLY TOXICITY TESTING MARKET, BY GEOGRAPHY 2014-2022 ($MILLION)
TABLE 15. GLOBAL NORTH AMERICA EARLY TOXICITY TESTING MARKET, BY TECHNIQUE 2014-2022 ($MILLION)
TABLE 16. GLOBAL NORTH AMERICA EARLY TOXICITY TESTING MARKET, BY END USERS 2014-2022 ($MILLION)
TABLE 17. GLOBAL NORTH AMERICA EARLY TOXICITY TESTING MARKET, BY COUNTRY 2014-2022 ($MILLION)
TABLE 18. GLOBAL NORTH AMERICA IN VITRO EARLY TOXICITY TESTING MARKET, BY ASSAY 2014-2022 ($MILLION)
TABLE 19. GLOBAL NORTH AMERICA IN VITRO EARLY TOXICITY TESTING MARKET, BY TOXICITY END-POINTS 2014-2022 ($MILLION)
TABLE 20. GLOBAL EUROPE EARLY TOXICITY TESTING MARKET, BY TECHNIQUE 2014-2022 ($MILLION)
TABLE 21. GLOBAL EUROPE EARLY TOXICITY TESTING MARKET, BY END USERS 2014-2022 ($MILLION)
TABLE 22. GLOBAL EUROPE EARLY TOXICITY TESTING MARKET, BY COUNTRY 2014-2022 ($MILLION)
TABLE 23. GLOBAL EUROPE IN VITRO EARLY TOXICITY TESTING MARKET, BY ASSAY 2014-2022 ($MILLION)
TABLE 24. GLOBAL EUROPE IN VITRO EARLY TOXICITY TESTING MARKET, BY TOXICITY END-POINTS 2014-2022 ($MILLION)
TABLE 25. GLOBAL ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TECHNIQUE 2014-2022 ($MILLION)
TABLE 26. GLOBAL ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY END USERS 2014-2022 ($MILLION)
TABLE 27. GLOBAL ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY COUNTRY 2014-2022 ($MILLION)
TABLE 28. GLOBAL ASIA-PACIFIC IN VITRO EARLY TOXICITY TESTING MARKET, BY ASSAY 2014-2022 ($MILLION)
TABLE 29. GLOBAL ASIA-PACIFIC IN VITRO EARLY TOXICITY TESTING MARKET, BY TOXICITY END-POINTS 2014-2022 ($MILLION)
TABLE 30. GLOBAL LAMEA EARLY TOXICITY TESTING MARKET, BY TECHNIQUE 2014-2022 ($MILLION)
TABLE 31. GLOBAL LAMEA EARLY TOXICITY TESTING MARKET, BY END USERS 2014-2022 ($MILLION)
TABLE 32. GLOBAL LAMEA EARLY TOXICITY TESTING MARKET, BY COUNTRY 2014-2022 ($MILLION)
TABLE 33. GLOBAL LAMEA IN VITRO EARLY TOXICITY TESTING MARKET, BY ASSAY 2014-2022 ($MILLION)
TABLE 34. GLOBAL LAMEA IN VITRO EARLY TOXICITY TESTING MARKET, BY TOXICITY END-POINTS 2014-2022 ($MILLION)
TABLE 35. THERMO FISHER: COMPANY SNAPSHOT
TABLE 36. THERMO FISHER: OPERATING SEGMENTS
TABLE 37. THERMO FISHER: PRODUCT PORTFOLIO
TABLE 38. BIO-RAD: COMPANY SNAPSHOT
TABLE 39. BIO-RAD: OPERATING SEGMENTS
TABLE 40. BIO-RAD: PRODUCT PORTFOLIO
TABLE 41. AGILENT: COMPANY SNAPSHOT
TABLE 42. AGILENT: OPERATING SEGMENTS
TABLE 43. AGILENT: PRODUCT PORTFOLIO
TABLE 44. QUEST DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 45. QUEST DIAGNOSTICS: OPERATING SEGMENTS
TABLE 46. QUEST DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 47. MERCK: COMPANY SNAPSHOT
TABLE 48. MERCK: OPERATING SEGMENTS
TABLE 49. MERCK: PRODUCT PORTFOLIO
TABLE 50. CHARLES RIVER: COMPANY SNAPSHOT
TABLE 51. CHARLES RIVER: OPERATING SEGMENTS
TABLE 52. CHARLES RIVER: PRODUCT PORTFOLIO
TABLE 53. BD: COMPANY SNAPSHOT
TABLE 54. BD: OPERATING SEGMENTS
TABLE 55. BD: PRODUCT PORTFOLIO
TABLE 56. DANAHER: COMPANY SNAPSHOT
TABLE 57. DANAHER: OPERATING SEGMENTS
TABLE 58. DANAHER: PRODUCT PORTFOLIO
TABLE 59. EVOTEC: COMPANY SNAPSHOT
TABLE 60. EVOTEC: OPERATING SEGMENTS
TABLE 61. EVOTEC: PRODUCT PORTFOLIO
TABLE 62. JAX: COMPANY SNAPSHOT
TABLE 63. JAX: PRODUCT PORTFOLIO
LIST OF FIGURE
FIGURE 1. GLOBAL EARLY TOXICITY TESTING MARKET: SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS: GLOBAL EARLY TOXICITY TESTING MARKET, BY END USERS
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2016)
FIGURE 4. PATENT REGISTERED/APPROVED- BY YEAR
FIGURE 5. PATENT REGISTERED/APPROVED- BY REGION
FIGURE 6. ENZYME TOXICITY ASSAYS FOR EARLY TOXICITY TESTING MARKET, 2014-2022 ($MILLION)
FIGURE 7. BACTERIAL TOXICITY ASSAYS FOR EARLY TOXICITY TESTING MARKET, 2014-2022($MILLION)
FIGURE 8. CELL-BASED ELISA AND WESTERN BLOTS FOR EARLY TOXICITY TESTING MARKET, 2014-2022($MILLION)
FIGURE 9. TISSUE CULTURE ASSAYS FOR EARLY TOXICITY TESTING MARKET, 2014-2022($MILLION)
FIGURE 10. RECEPTOR BINDING ASSAYS FOR EARLY TOXICITY TESTING MARKET, 2014-2022($MILLION)
FIGURE 11. OTHER IN VITRO ASSAYS FOR EARLY TOXICITY TESTING MARKET, 2014-2022($MILLION)
FIGURE 12. DERMAL TOXICITY FOR EARLY TOXICITY TESTING MARKET, 2014-2022
FIGURE 13. SYSTEMIC TOXICITY TESTS FOR EARLY TOXICITY TESTING MARKET, 2014-2022 ($MILLION)
FIGURE 14. CARCINOGENICITY FOR EARLY TOXICITY TESTING MARKET, 2014-2022 ($MILLION)
FIGURE 15. OCULAR TOXICITY FOR EARLY TOXICITY TESTING MARKET, 2014-2022 ($MILLION)
FIGURE 16. SKIN SENSITIZATION AND IRRITATION FOR EARLY TOXICITY TESTING MARKET, 2014-2022 ($MILLION)
FIGURE 17. GENOTOXICITY FOR EARLY TOXICITY TESTING MARKET, 2014-2022 ($MILLION)
FIGURE 18. NEUROTOXICITY FOR EARLY TOXICITY TESTING MARKET, 2014-2022 ($MILLION)
FIGURE 19. ORGAN TOXICITY FOR EARLY TOXICITY TESTING MARKET, 2014-2022 ($MILLION)
FIGURE 20. OTHER TOXICITY ENDPOINTS FOR EARLY TOXICITY TESTING MARKET, 2014-2022 ($MILLION)
FIGURE 21. U.S. EARLY TOXICITY TESTING MARKET, 2014-2022 ($MILLION)
FIGURE 22. CANADA EARLY TOXICITY TESTING MARKET, 2014-2022 ($MILLION)
FIGURE 23. MEXICO EARLY TOXICITY TESTING MARKET, 2014-2022 ($MILLION)
FIGURE 24. GERMANY EARLY TOXICITY TESTING MARKET, 2014-2022 ($MILLION)
FIGURE 25. FRANCE EARLY TOXICITY TESTING MARKET, 2014-2022 ($MILLION)
FIGURE 26. U.K. EARLY TOXICITY TESTING MARKET, 2014-2022 ($MILLION)
FIGURE 27. REST OF EUROPE EARLY TOXICITY TESTING MARKET, 2014-2022 ($MILLION)
FIGURE 28. JAPAN EARLY TOXICITY TESTING MARKET, 2014-2022 ($MILLION)
FIGURE 29. CHINA EARLY TOXICITY TESTING MARKET, 2014-2022 ($MILLION)
FIGURE 30. AUSTRALIA EARLY TOXICITY TESTING MARKET, 2014-2022 ($MILLION)
FIGURE 31. INDIA EARLY TOXICITY TESTING MARKET, 2014-2022 ($MILLION)
FIGURE 32. REST OF ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, 2014-2022 ($MILLION)
FIGURE 33. BRAZIL EARLY TOXICITY TESTING MARKET, 2014-2022 ($MILLION)
FIGURE 34. REPUBLIC OF SOUTH AFRICA EARLY TOXICITY TESTING MARKET, 2014-2022 ($MILLION)
FIGURE 35. REST OF LAMEA EARLY TOXICITY TESTING MARKET, 2014-2022 ($MILLION)
FIGURE 36. THERMO FISHER: REVENUE, 2014-2016 ($MILLION)
FIGURE 37. THERMO FISHER: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 38. THERMO FISHER: REVENUE SHARE, BY GEOGRAPHY, 2016 (%)
FIGURE 39. BIO-RAD: REVENUE, 2014-2016 ($MILLION)
FIGURE 40. BIO-RAD: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 41. BIO-RAD: REVENUE SHARE, BY GEOGRAPHY, 2016 (%)
FIGURE 42. AGILENT: REVENUE, 2014-2016
FIGURE 43. AGILENT: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 44. AGILENT: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 45. QUEST: REVENUE, 2014-2016 ($MILLION)
FIGURE 46. AGILENT: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 47. MERCK: REVENUE, 2014-2016 ($MILLION)
FIGURE 48. MERCK: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 49. MERCK: REVENUE SHARE, BY GEOGRAPHY, 2016 (%)
FIGURE 50. MERCK: STRATEGY SHARE, 2014-2016 (%)
FIGURE 51. CHARLES RIVER: REVENUE, 2014-2016 ($MILLION)
FIGURE 52. CHARLES RIVER: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 53. CHARLES RIVER: REVENUE SHARE, BY GEOGRAPHY, 2016 (%)
FIGURE 54. CHARLES RIVER: STRATEGY SHARE, 2014-2016 (%)
FIGURE 55. BD: REVENUE, 2014-2016 ($MILLION)
FIGURE 56. BD: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 57. BD: REVENUE SHARE, BY GEOGRAPHY, 2016 (%)
FIGURE 58. DANAHER: REVENUE, 2014-2016 ($MILLION)
FIGURE 59. DANAHER: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 60. DANAHER: REVENUE SHARE, BY GEOGRAPHY, 2016 (%)
FIGURE 61. EVOTEC: REVENUE, 2013-2015 ($MILLION)
FIGURE 62. EVOTEC: REVENUE SHARE BY SEGMENT, 2015 (%)
FIGURE 63. EVOTEC: REVENUE SHARE, BY GEOGRAPHY, 2015 (%)
FIGURE 64. EVOTEC: STRATEGY SHARE, 2014-2016 (%)
FIGURE 65. JAX: REVENUE, 2013-2015 ($MILLION)
FIGURE 66. JAX: STRATEGY SHARE, 2014-2016 (%)